Preoperative Muscle Health and Postoperative Outcomes in Older Adults with GI Cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational cohort study enrolling adults 60 years and older who are scheduled for elective gastrointestinal cancer surgery. Researchers will assess preoperative sarcopenia using EWGSOP2 criteria (strength, mass, and performance), plus SARC-F and calf measurements, to see if sarcopenia is linked to postoperative complications, length of stay, and 30- or 90-day mortality. Participants will be followed for 90 days after surgery, with standard perioperative care. The study will compare outcomes between those with and without preoperative sarcopenia to determine if sarcopenia is independently associated with worse postoperative results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 60 years or older
* Diagnosis of gastrointestinal system cancer
* Scheduled to undergo elective surgical treatment
* Considered operable based on routine clinical evaluation
* Ability to complete the preoperative sarcopenia assessments
* Provision of written informed consent

Exclusion Criteria:

* Age younger than 60 years
* Undergoing emergency surgery
* Inability to complete the required preoperative sarcopenia assessment

Where it's running

• Van Education and Research Hospital
  Van, Van, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: İbrahim Doğan, MD
• Email: dogan_203@hotmail.com
• Phone: +905313884966

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Bone marrow mesenchymal stem cell injection for sarcopenia

  This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.

  Recruiting Phase 1/2 GuangZhou Cellgenes Biotechnology Co., Ltd. · Guangzhou · NCT07865676

• GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes

  This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.

  Recruiting Istanbul Saglik Bilimleri University · Istanbul, Kucukcekmece · NCT07858864

• Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

  We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

  Recruiting Marmara University · Istanbul, Istanbul · NCT07855419

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

• Lower-limb rehabilitation robot training with nutrition education for sarcopenia

  In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.

  Recruiting Taipei Medical University Hospital · Taipei, Taipei City · NCT07830472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.